Rehabilitation Research News: August 21, 2020

From the Director's Desk

Greetings! On Monday, NICHD announced that I had been selected as the new director of NCMRR after serving as the acting director for the last year. I am incredibly humbled and grateful for the opportunity to continue leading the exceptional group of staff toward fulfilling the mission of NCMRR. I look forward to working with you all in this new capacity. On to the news!

COVID-19 Updates

The staff at NCMRR continue to be deeply concerned for the health and safety of people involved in NIH research and about the effects on the biomedical enterprise in the areas affected by the HHS-declared public health emergency for COVID-19. As many states slowly reopen, please refer to NIH’s notice emphasizing the importance of the safety and welfare of human subject participants and research staff. I encourage you to visit the NIH coronavirus webpage. The slides (PPT, 2.1 MB) and FAQs (DOC, 31.3 KB) have recently been updated to reflect the expiration of some of the flexibilities enacted in March. As you prepare applications for the fall deadlines, please be aware of the guidance notice for applicants and reviewers regarding contingency plans for COVID-19 in applications. Program staff are available if you have specific questions about your research project. Also please note that many new funding opportunity announcements were published this month as part of the RADx Program. More details about each funding opportunity can be found below.

Events

NIH Events

NCMRR is pleased to announce that registration is open for the Rehabilitation Research 2 020: Envisioning a Functional Future conference , October 15–16, 2020, in a completely virtual format. There is no cost to attend. We hope to see you there!
The National Center for Complementary and Integrative Health and the National Institute of Biomedical Imaging and Bioengineering are proud to join forces in organizing an NIH HEAL Initiative℠ workshop on myofascial pain, Quantitative Evaluation of Myofascial Tissues: Potential Impact for Musculoskeletal Pain Research. This workshop will take place online September 16–17, 2020. Register today.
The NIH Blueprint for Neuroscience Research is hosting a virtual workshop, Addressing Neuroimaging Challenges Across Populations and Settings, September 21–22, 2020. Register today.
The National Advisory Board for Medical Rehabilitation Research meeting was held on August 18^th and is available for viewing on the NIH VideoCast. This was rescheduled from May 4, 2020. The next meeting will be held December 7, 2020 in a virtual format.

Notices and Funding Opportunities

NICHD Notices and Funding Opportunities

COVID-19 NICHD Notices and Funding Opportunities

Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed)
- (RFA-OD-20-014)
- Multiple Institutes
- Application Receipt Date(s): September 15, 2020. No late applications will be accepted for this Funding Opportunity Announcement.
Emergency Awards RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed)
- (RFA-OD-20-017)
- Multiple Institutes
- Application Receipt Date(s): September 18, 2020. No late applications will be accepted for this Funding Opportunity Announcement.
Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed)
- (RFA-OD-20-019)
- Multiple Institutes
- Application Receipt Date(s): September 30, 2020. No late applications will be accepted for this Funding Opportunity Announcement.
Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 from Skin and the Oral Cavity (R44 Clinical Trial Not Allowed)
- (RFA-OD-20-020)
- Multiple Institutes
- Application Receipt Date(s): September 18, 2020
Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 from Skin and the Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed)
- (RFA-OD-20-021)
- Multiple Institutes
- Application Receipt Date(s): September 18, 2020
Emergency Awards: Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional)
- (RFA-OD-20-022)
- Multiple Institutes
- Application Receipt Date(s): September 15, 2020, by 5:00 PM local time of applicant organization. No late applications will be accepted for this Funding Opportunity Announcement.
Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional)
- (RFA-OD-20-023)
- Multiple Institutes
- Application Receipt Date(s): September 30, 2020. No late applications will be accepted for this Funding Opportunity Announcement.

Other NICHD Notices and Funding Opportunities

BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional)
- (RFA-MH-20-600)
- Multiple Institutes
- Application Receipt Date(s): July 14, 2021, July 14, 2022, and July 14, 2023 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement.

NIH Notices and Funding Opportunities

COVID-19 NIH Notices and Funding Opportunities

Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic
- (NOT-OD-20-158)
- National Institutes of Health
Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic
- (NOT-OD-20-163)
- National Institutes of Health
Emergency Awards: RADx-rad Wastewater Detection of SARS-COV-2 (COVID-19) (U01 Clinical Trials Not Allowed)
- (RFA-OD-20-015)
- Multiple Institutes
- Application Receipt Date(s): September 15, 2020. No late applications will be accepted for this Funding Opportunity Announcement.
Emergency Awards: RADx-RAD Multimodal COVID-19 Surveillance Methods for High Risk Clustered Populations (R01 Clinical Trial Optional)
- (RFA-OD-20-016)
- Multiple Institutes
- Application Receipt Date(s): September 30, 2020. No late applications will be accepted for this Funding Opportunity Announcement.
Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed)
- (RFA-OD-20-018)
- Multiple Institutes
- Application Receipt Date(s): September 18, 2020. No late applications will be accepted for this Funding Opportunity Announcement.

Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required)
- (RFA-TR-20-003)
- National Center for Advancing Translational Sciences
- Application Receipt Date(s): Applications will be accepted on a rolling basis, beginning on August 6, 2020. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Other NIH Notices and Funding Opportunities

Notice of Technical Assistance Webinar for Two NIH Multimorbidity FOAs — PAR-20-179 and PAR-20-180
- (NOT-OD-20-160)
- Office of Disease Prevention

Request for Information (RFI): Strategic Opportunities and Challenges for the National Library of Medicine, National Institutes of Health
- (NOT-LM-20-015)
- National Library of Medicine
Request for Information (RFI): Fostering Innovative Research to Improve Mental Health Outcomes Among Minority and Health Disparities Populations
- (NOT-MH-20-073)
- National Institute of Mental Health

Other Notices and Funding Opportunities

CDC's Management of Acute and Chronic Pain: Opportunity for Stakeholder Engagement

CDC released its companion Federal Register Notice to engage specific stakeholders on the management of acute and chronic pain. It is open for comment until August 21, 2020.

American Spinal Injury Association

The American Spinal Injury Association (ASIA) is very excited to announce the publication of the first issue of Topics in Spinal Cord Injury Rehabilitation (TSCIR) under ASIA’s new ownership. The next two issues are the first to solely be dedicated to primary care for people with spinal cord injuries and disorders.